Haleos Labs Ltd

Haleos Labs Q2 FY27 Results: Net Profit ₹1.8 Cr, Down 71.9% YoY

Haleos Labs Ltd reported revenue from operations of ₹91.4 Cr (+12.3% YoY) and net profit of ₹1.8 Cr (-71.9% YoY) for Q2 FY27.

Key figure

Net profit ₹1.8 Cr · -71.9% YoY

Haleos Labs Board Meeting Date

Haleos Labs scheduled its 99th board meeting for November 11, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until November 13, 2026.

Haleos Labs Other Announcement

Haleos Labs withheld FY2025-26 dividend for shareholders who have not updated KYC or bank details. Notices were sent to affected shareholders on 31 October 2026 pending compliance.

Haleos Labs Annual General Meeting

Haleos Labs Limited conducted its 20th Annual General Meeting on September 30, 2026. The meeting discussed financial statements, dividend declaration, and various director reappointments.

Haleos Labs Business Update

USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.